Asemblis is a Swiss-based biotech company (in the process of foundation) commited to advancing the frontiers of biofabrication through innovative research tools, strategic partnerships, and cutting-edge technologies. We work to empower scientists, accelerate clinical innovation, and bring to market scalable solutions that address today’s challenges while unlocking tomorrow’s potential.
All with integrity, collaboration, and bold mindset.
Supported by: